Generated by Rank Math SEO, this is an llms.txt file designed to help LLMs better understand and index this website.

# RetinaLyze System A/S: Safe, Fast and Efficient retinal investigations with AI and Telemedicine

## Sitemaps
[XML Sitemap](https://retinalyze.com/sitemap_index.xml): Includes all crawlable and indexable pages.

## Posts
- [RetinaLyze and OCULUS spol. s r.o. announce strategic cooperation to expand AI-powered eye screening across the Czechia](https://retinalyze.com/company-news/retinalyze-and-oculus-spol-s-r-o-announce-strategic-cooperation-to-expand-ai-powered-eye-screening-across-the-czechia/): RetinaLyze, a leader in AI-driven eye screening and tele-ophthalmology, today announced a strategic cooperation with OCULUS spol. s r.o.
- [A guide to handling patients who’ve used LLMs](https://retinalyze.com/general/a-guide-to-handling-patients-whove-used-llms/): Patients are increasingly arriving with AI-generated summaries from tools like ChatGPT, Gemini or Copilot. Some are better prepared. Others are more anxious. Most sit somewhere in between: informed, but not clinically grounded.
Handled poorly, AI-informed patients extend consult time. Handled strategically, they can shorten it.
- [RetinaLyze launches redesigned clinical PDF report – clearer communication for colleagues and patients](https://retinalyze.com/company-news/retinalyze-launches-redesigned-clinical-pdf-report-clearer-communication-for-colleagues-and-patients/): RetinaLyze is introducing a new, streamlined PDF report that will be available to all customers starting 15 January 2026. The redesign strengthens one of the most important touchpoints in the diagnostic workflow: how results are communicated to colleagues, referrers, and patients.
- [RetinaLyze introduces 3D ONH morphology visualization](https://retinalyze.com/glaucoma/retinalyze-introduces-3d-onh-morphology-visualization/): 3D visualization of the optic nerve head morphology from standard 2D retinal images. This innovation, based on the research recently published in BMJ Open Ophthalmology (2025), enables both optometrists and ophthalmologists to gain structural, perfusion-based insights previously accessible only through OCT.
- [RetinaLyze Year in Review 2025: A Year of Strong Science, New Integrations & Global Momentum](https://retinalyze.com/company-news/retinalyze-year-in-review-2025-a-year-of-strong-science-new-integrations-global-momentum/): As we turn the page on 2025, it’s remarkable to look back on the strides we’ve made at RetinaLyze System A/S.
- [Merry Christmas 2025!](https://retinalyze.com/company-news/merry-christmas-2025/): A thank you and a status to partners, distributors, customers and friends
- [RetinaLyze partners with FE-Group srl to strengthen AI-powered eye screening in Italy](https://retinalyze.com/company-news/retinalyze-partners-with-fe-group-srl-to-strengthen-ai-powered-eye-screening-in-italy/): RetinaLyze, a leader in AI-driven eye screening and tele-ophthalmology, today announced a strategic cooperation with Rockmed Vision to make accessible, high-quality retinal screening available to more patients and providers across the Benelux (the Netherlands, Belgium, and Luxembourg).
- [RetinaLyze and Rockmed Vision announce strategic cooperation to expand AI-powered eye screening across the Benelux](https://retinalyze.com/company-news/retinalyze-and-rockmed-vision-announce-strategic-cooperation-to-expand-ai-powered-eye-screening-across-the-benelux/): RetinaLyze, a leader in AI-driven eye screening and tele-ophthalmology, today announced a strategic cooperation with Rockmed Vision to make accessible, high-quality retinal screening available to more patients and providers across the Benelux (the Netherlands, Belgium, and Luxembourg).
- [Good clinical record-keeping for optometrists: a practical guide](https://retinalyze.com/optometry/good-clinical-record-keeping-for-optometrists-a-practical-guide/): Record-keeping is a legal obligation. It’s also the single most important piece of evidence if a case is reviewed by a complaints or disciplinary body.
- [RetinaLyze and EyeVinci Announce Strategic Distribution Partnership in the Dutch Market](https://retinalyze.com/company-news/retinalyze-and-eyevinci-announce-strategic-distribution-partnership-in-the-dutch-market/): RetinaLyze System A/S, a pioneer in artificial intelligence (AI) and telemedicine solutions for eye care, is excited to announce a strategic partnership with Eyevinci B.V, a leading provider of digital healthcare innovation.
- [Medibrix and RetinaLyze Announce Strategic Cooperation to Enhance Eye Health Services](https://retinalyze.com/company-news/medibrix-and-retinalyze-announce-strategic-cooperation-to-enhance-eye-health-services/): Medibrix, a leading provider of innovative digital healthcare solutions, and RetinaLyze System A/S, a pioneer in AI-based eye screening technology, are proud to announce a new cooperation aimed at improving access to efficient eye health screening through the Medibrix platform.
- [Wet AMD with CNV](https://retinalyze.com/stories/wet-amd-with-cnv/): A 79-year-old patient recently visited an optometrist using RetinaLyze System for a routine eye check. The optometrist noted abnormal findings on both fundus images and OCT scans.
- [RetinaLyze and Bloss Group Announce Strategic Distribution Partnership in the Spanish Market](https://retinalyze.com/company-news/retinalyze-and-bloss-group-announce-strategic-distribution-partnership-in-the-spanish-market/): RetinaLyze System A/S, a leading provider of artificial intelligence and telemedicine solutions for the optometry and healthcare industries, is pleased to announce a strategic distribution partnership with Bloxx Digital Innovation, a Bloss Group company.
- [RetinaLyze and Romger General Trade & Consulting Announce Strategic Distribution Partnership in Romania](https://retinalyze.com/company-news/retinalyze-and-romger-general-trade-consulting-announce-strategic-distribution-partnership-in-romania/): RetinaLyze System A/S, a leading provider of artificial intelligence and telemedicine solutions for optometry and healthcare, is pleased to announce a strategic distribution partnership with Romger General Trade & Consulting S.R.L.
- [RetinaLyze and Surveye Announce Strategic Distribution Partnership in the Slovak Market](https://retinalyze.com/company-news/retinalyze-and-surveye-announce-strategic-distribution-partnership-in-the-slovak-market/): Copenhagen, Denmark and Bratislava, Slovakia – January 28, 2024 – RetinaLyze System A/S, a leading provider of artificial intelligence (AI) and telemedicine solutions for the optometry and healthcare industries, is pleased to announce a new strategic distribution partnership with Surveye s.r.o
- [How to Appraise and Use AI in Optometry: Key Takeaways for Clinicians](https://retinalyze.com/optometry/how-to-appraise-and-use-ai-in-optometry-key-takeaways-for-clinicians/): Here is a concise overview of how clinicians can appraise and integrate AI-based technologies such as RetinaLyze into everyday practice.
- [Merry Christmas 2024!](https://retinalyze.com/company-news/merry-christmas-2024/): A thank you and a status to partners, distributors, customers and friends
- [RetinaLyze and Medicontur CZ Announce Strategic Distribution Partnership in the Czech Republic](https://retinalyze.com/company-news/retinalyze-and-medicontur-cz-announce-strategic-distribution-partnership-in-the-czech-republic/): Copenhagen, Denmark and Brno, Czech Republic – 10.12.2024 – RetinaLyze System A/S, a leading provider of artificial intelligence and telemedicine solutions for the optometry and healthcare industries, is pleased to announce a strategic distribution partnership with Medicontur CZ s.r.o.
- [Reflecting on 2024 at RetinaLyze: A Year of Innovation, Growth, and Impact](https://retinalyze.com/company-news/reflecting-on-2024-at-retinalyze-a-year-of-innovation-growth-and-impact/): As we turn the page on 2024, it’s remarkable to look back on the strides we’ve made at RetinaLyze System A/S.
- [RetinaLyze Unveils Advanced Glaucoma Progression AI with Glaucoma Index of Progression (GIP)](https://retinalyze.com/ophthalmology/retinalyze-unveils-advanced-glaucoma-progression-ai-with-glaucoma-index-of-progression-gip/): In alignment with World Sight Day 2024's theme “Children, Love Your Eyes,” RetinaLyze has announced the launch of its Advanced Glaucoma Progression AI.
- [Getting Started with Eye Screening as an Optometrist: Here’s how you do it!](https://retinalyze.com/optometry/getting-started-with-eye-screening-as-an-optometrist-heres-how-you-do-it/): If you're considering adding eye screening services to your practice, there are several important factors to keep in mind.
- [Consultations for ESBs and a new PDF report](https://retinalyze.com/product-updates/consultations-for-esbs-and-a-new-pdf-report/): This update focuses on streamlining workflows for optometrists and enhancing the accessibility of data for both users and external specialists.
- [Summer holidays are over, what’s happened with RetinaLyze?](https://retinalyze.com/product-updates/summer-holidays-are-over-whats-happened-with-retinalyze/): As we step into the latter part of the year, it’s the perfect time to reflect on the exciting developments that have unfolded at RetinaLyze in 2024. Our commitment to enhancing eye care through cutting-edge technology has led to several significant advancements that we’re thrilled to share.
- [RetinaLyze featured in The College of Optometrists Acuity Spring 2024](https://retinalyze.com/optometry/the-college-of-optometrists-acuity-spring-2024/): We are incredibly grateful for the opportunity to contribute to this significant discussion on the future of health diagnostics through oculomics, as featured in a recent publication called “Is early diagnosis always better” by The College of Optometrists.
- [RetinaLyze launches a new software version to enhance the workflow of the eye specialist](https://retinalyze.com/product-updates/retinalyze-launches-a-new-software-version-to-enhance-the-workflow-of-the-eye-specialist/): RetinaLyze has launched a new version of their fundus analysis software offering a range of improvements designed to streamline workflows and assist in decision-making.
- [RetinaLyze AI shows an AUC of 93,4% in new Ph.D. thesis](https://retinalyze.com/ophthalmology/retinalyze-ai-shows-an-auc-of-93-4-in-new-ph-d-thesis-explores-the-use-of-artificial-intelligence-in-screening-for-diabetic-retinal-changes-in-diabetes-patients/): New Ph.D. thesis explores the use of artificial intelligence in screening for diabetic retinal changes in diabetes patients.
- [Meet RetinaLyze at OPTI 2023](https://retinalyze.com/events-fairs/meet-retinalyze-at-opti-2023/): Artificial intelligence and eye screening: A topic that has been discussed in recent weeks not only in webinars, but generally in the industry. Those who have not yet had the chance to experience an AI-based eye screening live can do so at any time at OPTI 2023. The algorithms of RetinaLyze allow eye screening using artificial intelligence with fundus cameras or OCT devices.
- [RetinaLyze System receives ISO 13485:2016 certification](https://retinalyze.com/company-news/retinalyze-system-receives-iso-13485-2016-certification/): RetinaLyze System's quality management system has been independently audited to be compliant with ISO 13485:2016.
- [Launching RetinaLyze OCT – detect over 70 pathological signs in 45 seconds](https://retinalyze.com/product-updates/launching-retinalyze-oct-detect-over-70-pathological-signs-in-45-seconds/): We are excited to introduce our groundbreaking new service, RetinaLyze OCT, that supports optometrists in detecting more than 70 pathological signs of retinal conditions.
- [Video presentation of RetinaLyze Glaucoma by Prof. Manuel González de la Rosa](https://retinalyze.com/ophthalmology/video-presentation-of-retinalyze-glaucoma-by-prof-manuel-gonzalez-de-la-rosa/): Presentation of Laguna ONhE/RetinaLyze Glaucoma for the Department of Ophthalmology of the Complutense University of Madrid in 2020 by Prof. Manuel González de la Rosa of Insoft SL.
- [Abnormal GDF with few areas of low hemoglobin concentration](https://retinalyze.com/ophthalmology/abnormal-gdf-with-few-areas-of-low-hemoglobin-concentration/): Guest post by Prof. Manuel Gonzalez de la Rosa: How can a very abnormal GDF, be compatible with the presence of only a few areas of low hemoglobin concentration?
- [Paper accepted in Br J Ophthal. demonstrating that RetinaLyze Glaucoma has a similar diagnostic capability to Angio-OCT](https://retinalyze.com/ophthalmology/paper-accepted-in-br-j-ophthal-demonstrating-that-retinalyze-glaucoma-has-a-similar-diagnostic-capability-to-angio-oct/): A paper has been accepted in the prestigious British Journal of Ophthalmology, demonstrating that Laguna ONhE/RetinaLyze Glaucoma has a diagnostic capability similar to a modern and expensive Angio-OCT.
- [opti2020 – RetinaLyze is proud of the successful start to 2020](https://retinalyze.com/events-fairs/opti2020-retinalyze-is-proud-of-the-successful-start-to-2020/): The entire RetinaLyze team and their partners were close to our customers this year. At a total of six exhibition stands, visitors were able to learn more about eye screening using artificial intelligence.
- [Meet RetinaLyze at OPTI 2020](https://retinalyze.com/events-fairs/meet-retinalyze-at-opti-2020/): Meet us at OPTI 2020 and try the artificial intelligence enabled eye-screening software, RetinaLyze. Find us in Hall C6 Booth 426 from the 10th to the 12th of January 2020
- [RetinaLyze v3.7.1](https://retinalyze.com/product-updates/retinalyze-v3-7-1/): We are proud to present RetinaLyze version 3.7.1, which consists of upgrades to the Glaucoma algorithm.
- [Prof. Gonzalez de la Rosa presents new groundbreaking performance of the Laguna ONhE/RetinaLyze Glaucoma algorithm](https://retinalyze.com/company-news/prof-gonzalez-de-la-rosa-presents-new-groundbreaking-performance-of-the-laguna-onhe-retinalyze-glaucoma-algorithm/): Professor Gonzalez de la Rosa (GR), prime inventor of the Laguna ONhE/RetinaLyze Glaucoma algorithm, was invited to lecture at two recent meetings in Madrid.
- [2018 – Year in review and our fifth birthday!](https://retinalyze.com/company-news/looking-back-at-retinalyzes-2018/): 2018 was quite a year for RetinaLyze System A/S (Ltd.). We launched the glaucoma-algorithm, gave RetinaLyze a visual overhaul and reached 1 million screenings for Diabetic Retinopathy, AMD and Glaucoma!
- [RetinaLyze receives funding to detect diseases such as Alzheimer’s using AI](https://retinalyze.com/company-news/retinalyze-teams-up-with-two-universities-to-detect-diseases-such-as-alzheimers-through-the-eyes/): RetinaLyze teams up with two universities to develop the next generation of eye screening algorithms, which may detect new diseases in retinal images, such as Alzheimer's.
- [AI as an efficient co-pilot in the detection of diseases causing preventable blindness](https://retinalyze.com/events-fairs/ai-as-an-efficient-co-pilot-in-the-detection-of-diseases-causing-preventable-blindness/): The Rotary Medical Mission (RMM) is in Malawi to provide free eye services including provision of eye and sun glasses, and check ups. Our Head of Global Sales, Lasse Bundgaard, joined them in Lilongwe, Malawi at the Kamuzu Central Hospital.
- [RetinaLyze v3.2.0](https://retinalyze.com/product-updates/retinalyze-v3-2-0/): We are proud to present RetinaLyze version 3.2.0, which consists of major upgrades to the Glaucoma algorithm and smaller changes to make the system easier to use.
- [Partnership announced at IX Biennial Congress of Glaucoma 2018](https://retinalyze.com/events-fairs/partnership-announced-at-ix-biennial-congress-of-glaucoma-2018/): We're proud to announce our partnership with Unica Pharma, who launched the RetinaLyze Glaucoma software in Argentina this weekend. The software was presented by Dr. Jens Thygesen at the IX Biennial Congress of Glaucoma organized by ASAG.
- [Why it’s important to have your eyes screened for glaucoma](https://retinalyze.com/ophthalmology/why-its-important-to-have-your-eyes-screened-for-glaucoma/): In this article, we're going to be specifically looking at the importance of regular eye checks and what happens if you neglect to visit your local GP, or ophthalmic specialist.
- [Training session in Kenya](https://retinalyze.com/events-fairs/training-session-in-kenya/): Here is a series of images taken during a training session Terry Cooper and Paul Machengo attended at Coast Provincial General Hospital in Mombasa, Kenya.
- [RetinaLyze’ new AI algorithm detects signs of glaucoma using retinal images](https://retinalyze.com/company-news/retinalyze-new-ai-algorithm-detects-glaucoma-using-retinal-images/): A team of researchers have developed an algorithm, which automatically detects abnormalities and changes linked to the eye disease glaucoma. The new algorithm is now offered as a part of the software, RetinaLyze, which provides instant eye screening results for the 3 most frequent diseases causing blindness glaucoma, macular degeneration and diabetic retinopathy.
- [RetinaLyze Glaucoma – A revolution in glaucoma screening](https://retinalyze.com/product-updates/retinalyze-glaucoma-a-revolution-in-glaucoma-screening/): We are excited to present a fantastic new service in the RetinaLyze portfolio. RetinaLyze Glaucoma can screen for glaucoma using only fundus images, but achieves similar performance to OCT's and visual perimetry.
- [Glaucoma is now the second leading cause of blindness](https://retinalyze.com/ophthalmology/glaucoma-regular-eye-exams-prevent-loss-of-sight/): Glaucoma is becoming an increasingly important cause of blindness, as the world’s population ages. New statistics gathered by WHO in 2002, show that glaucoma is now the second leading cause of blindness globally, after cataracts.
- [OPTI 2018](https://retinalyze.com/events-fairs/opti-2018/): Danke! Thank you! Grazie! Merci! Gracias! Teşekkür ederiz! Bedankt! Спасибо! 谢谢! The RetinaLyze team thanks all visitors for a great fair in Munich and look forward to opti 2019!
- [Looking back at RetinaLyze’s 2017](https://retinalyze.com/company-news/looking-back-at-retinalyzes-2017/): Wow, 2017 was quite a year for RetinaLyze System A/S. We've screened over 150.000 people for Diabetic Retinopathy and AMD, won an award and launched both massive features and a host of enhancements.
- [Meet RetinaLyze at OPTI 2018](https://retinalyze.com/events-fairs/meet-retinalyze-at-opti-2018/): Meet us at OPTI 2018 and try the artificial intelligence enabled eye-screening software, RetinaLyze. Find us in Hall C4 Stand 525 from the 12th to the 14th of January 2018
- [RetinaLyze wins award](https://retinalyze.com/company-news/retinalyze-wins-careware-next-entrepreneur-2017-award/): Aarhus Municipality and CareWare-Next awarded the CareWare-Next prizes, the nationwide competition for welfare technology, on Tuesday November 14th.

## Pages
- [FAQ](https://retinalyze.com/faq/): Find answers to the most asked questions right here. If you don't find your answer, get in touch with us here.
- [Collaborate on AI development](https://retinalyze.com/collaborate-on-ai-development/): Request a demonstration and try RetinaLyze® for free. RetinaLyze® is a screening software, which aids eye care professionals in screening for eye diseases in a safe and efficient manner.
- [Data Processing Agreement](https://retinalyze.com/dpa/): At RetinaLyze System A/S (Ltd.), a Danish corporation (“RetinaLyze System”, “Company”, “us”, or “we”), we respect and protect the privacy of visitors to our website, retinalyze.com, and the other websites under the retinalyze.com domain (collectively, the “Sites”), and our customers who use our SaaS product, eye screening software, tools, and related services (together with the Sites, the “Service”).
- [Free trial of RetinaLyze](https://retinalyze.com/free-trial/): Request a demonstration and try RetinaLyze® for free. RetinaLyze® is a screening software, which aids eye care professionals in screening for eye diseases in a safe and efficient manner.
- [Careers](https://retinalyze.com/careers/): Join our team! Find the latest open positions here and get started working in the field of eye-screening, optometry, ophthalmology and AI.
- [About us](https://retinalyze.com/about-us/): With RetinaLyze, we’ve made that change. We’ve turned eye screening into something that works for you.
- [Become a distributor](https://retinalyze.com/become-distributor/): RetinaLyze has the tools you need for safe, efficient and easy eye-screening.What are you looking for?
- [Contact us](https://retinalyze.com/contact/): If you're unsure who to contact, please send your request to info@retinalyze.com and we'll make sure the right person responds.
- [Change your cookie settings](https://retinalyze.com/cookie-settings/): Change cookie settings
- [Contact Sales](https://retinalyze.com/contact-sales/): RetinaLyze has the tools you need for safe, efficient and easy eye-screening.What are you looking for?
- [Blog](https://retinalyze.com/blog/): Learn what's new in Optometry, Ophthalmology and RetinaLyze.
- [Research](https://retinalyze.com/research/): The latest clinical studies and validation reports available for free.
- [Privacy Policy](https://retinalyze.com/privacy-policy/): This Privacy Policy (“Policy”) explains how we collect, use, disclose, and protect visitors’ and users’ information as part of the Service. Any discussion of your use of the Service in this Policy is meant to include your visits and other interactions with the Sites and Services, whether or not you are a user of RetinaLyze System's SaaS product.
- [Faster, safer eye screenings](https://retinalyze.com/): We help eye care professionals perform screenings for signs of pathology. Safely and efficiently using AI and tele-medicine.

## Distributors
- [OCULUS spol. s r. o.](https://retinalyze.com/local-dealer/oculus-spol-s-r-o/)
- [Rockmed Luxembourg](https://retinalyze.com/local-dealer/rockmed-luxembourg/)
- [Rockmed België](https://retinalyze.com/local-dealer/rockmed-vision-2/)
- [Rockmed Vision](https://retinalyze.com/local-dealer/rockmed-vision/)
- [EyeVinci B.V.](https://retinalyze.com/local-dealer/eyevinci-b-v/)
- [RetinaLyze UK Ltd.](https://retinalyze.com/local-dealer/retinalyze-uk-ltd/)
- [RetinaLyze System Switzerland GmbH](https://retinalyze.com/local-dealer/retinalyze-system-switzerland-gmbh-switzerland/)
- [RetinaLyze System A/S](https://retinalyze.com/local-dealer/retinalyze-system-a-s-sweden/)
- [Bloxx Digital Innovation by Bloss Group](https://retinalyze.com/local-dealer/bloxx-digital-innovation-by-bloss-group/)
- [RetinaLyze System Espana SL](https://retinalyze.com/local-dealer/retinalyze-system-espana-sl/)
- [Surveye s.r.o.](https://retinalyze.com/local-dealer/surveye-s-r-o/)
- [Romger General Trade & Consulting](https://retinalyze.com/local-dealer/romger-general-trade-consulting/)
- [E-Distribution Sp. z o.o.](https://retinalyze.com/local-dealer/e-distribution-sp-z-o-o/)
- [RetinaLyze System A/S](https://retinalyze.com/local-dealer/retinalyze-system-a-s-norway/)
- [FE-Group srl](https://retinalyze.com/local-dealer/fe-group-srl/)
- [RetinaLyze System Switzerland GmbH](https://retinalyze.com/local-dealer/retinalyze-system-switzerland-gmbh-germany/)
- [RetinaLyze System A/S](https://retinalyze.com/local-dealer/retinalyze-system-a-s-finland/)
- [RetinaLyze System A/S](https://retinalyze.com/local-dealer/retinalyze-system-a-s-denmark/)
- [Medicontur CZ s.r.o.](https://retinalyze.com/local-dealer/medicontur-cz-s-r-o/)
- [Ávita Care Importação e Distribuição de Produtos LTDA](https://retinalyze.com/local-dealer/avita-care-importacao-e-distribuicao-de-produtos-ltda-brazil/)
- [RetinaLyze System Switzerland GmbH](https://retinalyze.com/local-dealer/retinalyze-system-switzerland-gmbh-austria/)

## Research Articles
- [The diagnostic accuracy of AI-assisted diabetic retinopathy screening in primary care: a prospective validation study](https://retinalyze.com/research-article/the-diagnostic-accuracy-of-ai-assisted-diabetic-retinopathyscreening-in-primary-care-a-prospective-validation-study/): Objectives:This study investigated the diagnostic accuracy of AI-assisted diabetic retinopathy screening in primary care, using ophthalmologist-led screening as the reference standard.
- [Combined diagnostic accuracy of two artificial intelligence systems for glaucoma diagnosis using color fundus photography](https://retinalyze.com/research-article/combined-diagnostic-accuracy-of-two-artificial-intelligence-systems-for-glaucoma-diagnosis-using-color-fundus-photography/): PurposeTo evaluate the diagnostic accuracy of two commercially available artificial intelligence (AI) systems based on color fundus photography (CFP), the Laguna ONhE and VUNO Med-Fundus AI, for glaucoma detection, both independently and in combination.
- [Patient acceptance of AI-assisted diabetic retinopathy screening in primary care: findings from a questionnaire-based feasibility study](https://retinalyze.com/research-article/patient-acceptance-of-ai-assisted-diabetic-retinopathy-screening-in-primary-care-findings-from-a-questionnaire-based-feasibility-study/): Aim: This feasibility study investigates patients' acceptance of AI-assisted diabetic retinopathy screening (DRS) in primary care.
- [Correlation of optic nerve hemoglobin levels with structural and functional parameters in glaucoma](https://retinalyze.com/research-article/correlation-of-optic-nerve-hemoglobin-levels-with-structural-and-functional-parameters-in-glaucoma/): Glaucoma is a chronic and progressive eye disease that leads to irreversible damage to the optic nerve and retinal nerve fiber layer, resulting in visual field loss. Abnormalities in retinal blood flow and vascular regulation are increasingly recognized as key factors in glaucoma development.
- [Valuable insights into general practice staff’s experiences and perspectives on AI-assisted diabetic retinopathy screening—An interview study](https://retinalyze.com/research-article/valuable-insights-into-general-practice-staffs-experiences-and-perspectives-on-ai-assisted-diabetic-retinopathy-screening-an-interview-study/): Aim‍This study explores the hands-on experiences and perspectives of general practice staff regarding the feasibility of conducting artificial intelligence-assisted (AI-assisted) diabetic retinopathy screenings (DRS) in general practice settings.
- [Assessment of Structural Progression in Glaucoma Through Automated Optic Nerve Head Hemoglobin Measurements](https://retinalyze.com/research-article/assessment-of-structural-progression-in-glaucoma-through-automated-optic-nerve-head-hemoglobin-measurements/): Purpose‍To assess the performance of automated optic nerve head hemoglobin measurements (ONH Hb) for detection of structural progression in glaucoma patients using event analysis.
- [Estimation of normal and glaucomatous optic nerve morphology from perfusion](https://retinalyze.com/research-article/estimation-of-normal-and-glaucomatous-optic-nerve-morphology-from-perfusion/): ObjectiveTo estimate the optic nerve head morphology from its haemoglobin (Hb) distribution.
- [Frequency of the vertical cup-to-disc ratio to normal optical disc size](https://retinalyze.com/research-article/frequency-of-the-vertical-cup-to-disc-ratio-tonormal-optical-disc-size/): The relationship between the optic disc area and the vertical cup/disc ratio is presented by means of a graphic nomogram after studying a total of 365,356 normal optic nerves. For this purpose, the Laguna ONhE application was used, which analyses the distribution of hemoglobin based on the colorimetric analysis of fundus color images.
- [Identification of Glaucoma in Diabetics Using the Laguna-ONhE Colourimetric Method and OCT Spectralis](https://retinalyze.com/research-article/identification-of-glaucoma-in-diabetics-using-the-laguna-onhe-colourimetric-method-and-oct-spectralis/): BackgroundPrevious retrospective results are evaluated prospectively and blinded.
- [Agreement between Five Experts and the Laguna ONhE Automatic Colourimetric Application Interpreting the Glaucomatous Aspect of the Optic Nerve](https://retinalyze.com/research-article/agreement-between-five-experts-and-the-laguna-onhe-automatic-colourimetric-application-interpreting-the-glaucomatous-aspect-of-the-optic-nerve/): BackgroundOptic nerve head (ONH) interpretation is a glaucoma screening method which may be influenced by criteria variability. Laguna ONhE software (also known as RetinaLyze Glaucoma) is a low-cost and non-invasive method of ONH analysis.
- [Performance of a Support Vector Machine Learning Tool for Diagnosing Diabetic Retinopathy in Clinical Practice](https://retinalyze.com/research-article/performance-of-a-support-vector-machine-learning-tool-for-diagnosing-diabetic-retinopathy-in-clinical-practice/): PURPOSETo examine the real-world performance of a support vector machine learning software (RetinaLyze) in order to identify the possible presence of diabetic retinopathy (DR) in patients with diabetes via software implementation in clinical practice.
- [Glaucoma Incidence and Progression in Diabetics: The Canary Islands Study Using the Laguna ONhE Application](https://retinalyze.com/research-article/glaucoma-incidence-and-progression-in-diabetics-the-canary-islands-study-using-the-laguna-onhe-application/): BackgroundLaguna ONhE provides a globin distribution function (GDF), in which a glaucoma discriminator based on deep learning plays an important role, and there is also an optimized globin individual pointer (GIP) for progression analysis.
- [Comparison of age-related vascular changes in the optic disc of patients with diabetes, with glaucomatous and non-glaucomatous features](https://retinalyze.com/research-article/comparison-of-age-related-vascular-changes-in-the-optic-disc-of-patients-with-diabetes-with-glaucomatous-and-non-glaucomatous-features/): Objective‍To identify age-related vascular changes in the optic discs of patients with diabetes with and without signs of glaucoma.
- [Discrimination Between Healthy Eyes and Those With Mild Glaucoma Damage Using Hemoglobin Measurements of the Optic Nerve Head](https://retinalyze.com/research-article/discrimination-between-healthy-eyes-and-those-with-mild-glaucoma-damage-using-hemoglobin-measurements-of-the-optic-nerve-head/): PrécisThe Laguna ONhE, a software that measures the hemoglobin (Hb) concentration of the optic nerve head (ONH) from fundus photographs, demonstrated good accuracy in discriminating healthy eyes from eyes with mild glaucoma.
- [Optic disc area frequency distribution in a large sample of retinographic images](https://retinalyze.com/research-article/optic-disc-area-frequency-distribution-in-a-large-sample-of-retinographic-images/): Objective‍To describe a new method to estimate the frequency distribution of optic nerve disc area, using digital retinographic images.
- [Optic Nerve Head Hemoglobin Levels in Glaucoma: A Structural and Functional Correlation Study](https://retinalyze.com/research-article/optic-nerve-head-hemoglobin-levels-in-glaucoma-a-structural-and-functional-correlation-study/): PurposeTo investigate structural and functional correlations in glaucoma patients using optic nerve head hemoglobin (ONH Hb) measurements as determined by automated colorimetric analysis of conventional retinography.
- [Fully Automated Colorimetric Analysis of the Optic Nerve Aided by Deep Learning and Its Association with Perimetry and OCT for the Study of Glaucoma](https://retinalyze.com/research-article/fully-automated-colorimetric-analysis-of-the-optic-nerve-aided-by-deep-learning-and-its-association-with-perimetry-and-oct-for-the-study-of-glaucoma/): BackgroundLaguna-ONhE is an application for the colorimetric analysis of optic nerve images, which topographically assesses the cup and the presence of haemoglobin. Its latest version has been fully automated with five deep learning models. In this paper, perimetry in combination with Laguna-ONhE or Cirrus-OCT was evaluated.
- [Non invasive evaluation of the aging of the cristaline lens in normals and diabetics](https://retinalyze.com/research-article/non-invasive-evaluation-of-the-aging-of-the-cristaline-lens-in-normals-and-diabetics/): Purpose‍The color of the optic nerve's central vessels, visible over the white myelin background, may serve as a reference to evaluate the increase in lens absorption to short wavelength radiation. It would allow observing premature lens aging in diabetic patients.‍
- [New gip index for progression analysis, ussing the laguna ohne method for the optic nerve head hemoglobin evaluation](https://retinalyze.com/research-article/new-gip-index-for-progression-analysis-ussing-the-laguna-ohne-method-for-the-optic-nerve-head-hemoglobin-evaluation/): PurposeLaguna ONhE automatically analyzes hemoglobin distribution in optic disc retinographies (1-9). Its main index, called GDF (Globin Distribution Factor) involves a classifier based on Deep Learning that tends to produce extreme values: (1=normal, 0=glaucoma). The consequence is a good detection performance, outweighed by certain variability in the limit range between normality and glaucoma. Therefore, its influence has been reduced in a new index, called Globin Individual Pointer (GIP). It may be useful in the follow-up of cases.
- [Fully automated Deep Learning analysis of hemoglobin images of the optic nerve associated with perimetry for the study of glaucoma](https://retinalyze.com/research-article/fully-automated-deep-learning-analysis-of-hemoglobin-images-of-the-optic-nerve-associated-with-perimetry-for-the-study-of-glaucoma/): Purpose‍Colorimetric analysis of optic nerve images for assessing their hemoglobin distribution (Laguna ONhE) (1-4) is tested in combination with perimetry.
- [Glaucoma screening in 285,320 optic disc color images using laguna onhe hemoglobin distribution analysis](https://retinalyze.com/research-article/glaucoma-screening-in-285320-optic-disc-color-images-using-laguna-onhe-hemoglobin-distribution-analysis/): Purpose‍To assess a mass screening in general population, mainly European, using the Laguna ONhE system to detect glaucoma.‍
- [Diagnostic validity of optic nerve head colorimetric assessment and optical coherence tomography angiography in patients with glaucoma](https://retinalyze.com/research-article/diagnostic-validity-of-optic-nerve-head-colorimetric-assessment-and-optical-coherence-tomography-angiography-in-patients-with-glaucoma/): PurposeThe aim of this study was to assess the optic nerve head (ONH) and macular vessel density with optical coherence tomography angiography (OCT-A) and the ONH haemoglobin (ONH Hb) amount with Laguna ONhE program in open-angle glaucoma (OAG) patients.
- [Gold standards may bias clinical test validation](https://retinalyze.com/research-article/gold-standards-may-bias-clinical-test-validation/): The use of a Gold Standard may be an option acceptable when its precision is well known and not it is expected that the evaluated procedure can be more exactly. But when the Gold Standard is imperfect or worse than the one judged, the conclusions of the evaluation are generally inaccurate. its utilization can not only underestimate the method evaluated, but offer incorrect results, especially when it has been used for selection of the samples.
- [Segmentation of the Optic Nerve Head Based on Deep Learning to Determine its Hemoglobin Content in Normal and Glaucomatous Subjects](https://retinalyze.com/research-article/segmentation-of-the-optic-nerve-head-based-on-deep-learning-to-determine-its-hemoglobin-content-in-normal-and-glaucomatous-subjects/): PurposeTo determine the limits of the optic nerve head (ONH) in color fundus images using Deep learning (DL) for the estimation of its hemoglobin topographic distribution. Also, to evaluate the usefulness of that distribution in glaucoma diagnosis singly or in association with perimetry.‍
- [Hemoglobin measurement in the optic nerve head using the Laguna ONhE program](https://retinalyze.com/research-article/hemoglobin-measurement-in-the-optic-nerve-head-using-the-laguna-onhe-program/): PurposeThe Laguna ONhE program divides conventional color images of the optic nerve head (ONH) into 24 sectors using two ellipses, approximately parallel to its edge, and four diametrical lines. It notes the differences between its red and green components and compensates the diversities of spectral composition of the illumination light, the absorption of the lens and the spectral response of the detector used by means a relative measure: the values of the tissue are divided by those obtained in the central vessels.
- [Relationship between Retinal Nerve Fiber Layer Thickness and Hemoglobin Present in the Optic Nerve Head in Glaucoma](https://retinalyze.com/research-article/relationship-between-retinal-nerve-fiber-layer-thickness-and-hemoglobin-present-in-the-optic-nerve-head-in-glaucoma/): PurposeTo observe the relationship between topographic hemoglobin levels in the optic nerve head (ONH), the rim thickness (BMO-MRW), and retinal nerve fiber layer (RNFL) thickness.
- [Preliminary study of differences in optic nerve head hemoglobin measures between childhood glaucoma patients and healthy volunteers](https://retinalyze.com/research-article/preliminary-study-of-differences-in-optic-nerve-head-hemoglobin-measures-between-childhood-glaucoma-patients-and-healthy-volunteers/): Purpose‍To evaluate the effectiveness of quantifying color changes in the optic nerve head in retinal photographs of patients with childhood glaucoma.‍
- [Reproducibility of the Laguna ONhE application with automatic segmentation of the limits of the optical nerve head, excavation and neuroretinal rim: Validation of new algorithms (Spanish)](https://retinalyze.com/research-article/reproducibility-of-the-laguna-onhe-application-with-automatic-segmentation-of-the-limits-of-the-optical-nerve-head-excavation-and-neuroretinal-rim-validation-of-new-algorithms-spanish/): PurposeTo compare the diagnostic accuracy and reproducibility of the Laguna ONhE program (with automatic segmentation of the optic nerve head cupping and neuro-retinal rim using new algorithms), with morphological (OCT) and functional (visual field) information.
- [Glaucoma diagnostic capacity of optic nerve head haemoglobin measures compared with spectraldomain OCT and HRT III confocal tomography](https://retinalyze.com/research-article/glaucoma-diagnostic-capacity-of-optic-nerve-head-haemoglobin-measures-compared-with-spectraldomain-oct-and-hrt-iii-confocal-tomography/): Similar diagnostic power for RetinaLyze Glaucoma, an OCT and a confocal tomography
- [Reproducibility of Optic Nerve Head Hemoglobin Measures](https://retinalyze.com/research-article/reproducibility-of-optic-nerve-head-hemoglobin-measures/): PurposeTo evaluate intraobserver, interobserver, within-session and between-session reproducibility of the measurement of optic nerve head (ONH) hemoglobin levels by color analysis using Laguna ONhE program.
- [Measuring Hemoglobin Levels in the Optic Nerve Head for Glaucoma Management](https://retinalyze.com/research-article/measuring-hemoglobin-levels-in-the-optic-nerve-head-for-glaucoma-management/): Description of the method Laguna ONhE (used by the RetinaLyze Glaucoma algorithm) that measures the amount of hemoglobin at the optic nerve head from color fundus pictures. It shows the basis of the method and its application to glaucoma and other pathologies that affect the optic nerve.
- [Estimating the Amount of Hemoglobin in the Neuroretinal Rim Using Color Images and OCT](https://retinalyze.com/research-article/estimating-the-amount-of-hemoglobin-in-the-neuroretinal-rim-using-color-images-and-oct/): The amount of Hb in the ONH has an important relationship with glaucomatous eyes
- [Optic Nerve Head hemoglobin levels in childhood glaucoma patients](https://retinalyze.com/research-article/optic-nerve-head-hemoglobin-levels-in-childhood-glaucoma-patients/): PurposeThe computer program Laguna ONhE determines optic nerve head hemoglobin (ONH Hb) on retinal photographs based on detecting colour differences. The software provides two diagnostic indices for glaucoma: estimated vertical cup-disc-ratio (C/D) and glaucoma discriminant function GDF). This study examines the amount of ONH Hb in patients with chilhood glaucoma using this new noninvasive technique.
- [Estimation of the Relative Amount of Hemoglobin in the Cup and Neuroretinal Rim Using Stereoscopic Color Fundus Images](https://retinalyze.com/research-article/estimation-of-the-relative-amount-of-hemoglobin-in-the-cup-and-neuroretinal-rim-using-stereoscopic-color-fundus-images/): PurposeTo calculate the relative amount of hemoglobin (Hb) in sectors of the optic nerve head (ONH) from stereoscopic color fundus images using the Laguna ONhE method and compare the results with the visual field evaluation and optical coherence tomography (OCT).
- [Correlating cup-to-disc ratios measured by HRT-III, SD-OCT and the new color imaging Laguna ONhE procedure (Spanish)](https://retinalyze.com/research-article/correlating-cup-to-disc-ratios-measured-by-hrt-iii-sd-oct-and-the-new-color-imaging-laguna-onhe-procedure-spanish/): PurposeTo examine correlations between cup-to-disc (C/D) ratios determined by the new Laguna ONhE (optic nerve hemoglobin) color imaging procedure, spectral domain optical coherence tomography (OCT), confocal scanning laser tomography using Heidelberg retina tomography (HRT), and examining retinal images.
- [Measuring Hemoglobin Levels in the Optic Nerve Head: Comparisons with Other Structural and Functional Parameters of Glaucoma](https://retinalyze.com/research-article/measuring-hemoglobin-levels-in-the-optic-nerve-head-comparisons-with-other-structural-and-functional-parameters-of-glaucoma/): PurposeWe evaluated and compared the ability of a new method for measuring hemoglobin (Hb) levels at the optic nerve head (ONH) to that of visual field evaluation, scanning laser ophthalmoscopy (HRT), scanning laser polarimetry (GDx), and optical coherence tomography (OCT) for diagnosing glaucoma.
- [A health economic analysis](https://retinalyze.com/research-article/a-health-economic-analysis/): Cut costs and time